In this week’s episode of ‘Ask Dr. J”, Dr. Russell Jaffe talks about recommendations of protocols to support the rebuilding of the immune status for chronic immune conditions.
Effective December 18, 2024, ELISA/ACT Biotechnologies will be temporarily closing for operational research and improvement